Abstract
The involvement of cholecystokinin (CCK) in the mechanisms of stress and/or anxiety was assessed by in vivomicrodialysis in rats subjected to a social stress paradigm. During the initial 30 min period of each conditioning session, a male Sprague Dawley rat (intruder) was placed in a protective cage inside the cage of a male Tryon Maze Dull rat (resident), allowing unrestricted visual, olfactory, and auditory contacts but precluding close physical contact between them. During the following 15 min period, both the protective cage and the resident were removed (nondefeated intruders) or only the protective cage was removed allowing the resident to attack the intruder (defeated rats). This procedure was repeated once daily for 4 d. On the fifth day, a guide cannula was implanted into the prefrontal cortex of intruders. During a single 30 min test session, performed 4 d later, intruders were subjected to only the 30 min protected confrontation to the resident. Anxiety-like behavior (immobility, ultrasonic vocalizations, and defensive postures), associated with an increase (approximately +100% above baseline) in cortical outflow of CCK-like material (CCKLM), were observed in defeated intruders. Pretreatment with diazepam (5 mg/kg, i.p.), but not buspirone (0.5–2 mg/kg, i.p.), prevented both the anxiety-related behavior and CCKLM overflow. The selective CCK-B receptor antagonist CI-988 (2 mg/kg, i.p.) reduced the anxiety-like behavior without affecting the increase in CCKLM outflow. These data indicate that anticipation of social defeat induces a marked activation of cortical CCKergic neurons associated with anxiety-related behaviors in rats.
Keywords: CCK, in vivo microdialysis, frontal cortex, anticipation of social defeat, anxiolytics, stress, anxiety
A large body of evidence supports the proposal that cholecystokinin (CCK) plays an important role in the neurobiological mechanisms of stress and/or anxiety. To date, two types of specific receptors, named CCK-A and CCK-B, are known to mediate the actions of this neuropeptide. Although CCK-A receptors are found primarily in the periphery, they are also present in a few brain areas (area postrema, interpeduncular nucleus, and nucleus of the solitary tract). On the other hand, CCK-B receptors are almost exclusively expressed in the CNS (Noble et al., 1999). Sulfated CCK-8 (CCK-8S) and other CCK-B receptor agonists, such as the tetrapeptide CCK-4, possess anxiogenic-like properties in various species (van Megen et al., 1996). In humans, administration of CCK-4 has been reported to provoke attacks in panic subjects (Bradwejn et al., 1990) and healthy volunteers (de Montigny, 1989). Conversely, selective CCK-B receptor antagonists produced anxiolytic-like effects in various animal paradigms (such as plus-maze and social interaction) (van Megen et al., 1996; Shlick et al., 1997; Daugé and Léna, 1998) and prevented CCK-4 from inducing panic attacks in humans (Bradwejn et al., 1994).
CCK-containing neurons are widely distributed throughout the brain, especially in corticolimbic structures such as the frontal cortex (Beinfeld et al., 1981; Marley et al., 1984; Iadarola et al., 1989). Increases in the tissue concentrations of CCK and the density of CCK receptors have been consistently reported in the cerebral cortex of rats subjected to anxiogenic situations (Siegel et al., 1984; Brodin et al., 1989; Harro et al., 1990, 1992; Vasar et al., 1993). Additionally, cortical extracellular CCK concentrations increased in rats subjected to stressful or anxiogenic-like stimuli (Nevo et al., 1996; Becker et al., 1999). However, the experimental paradigms used in these studies did not permit the assessment of a causal link between increased cortical CCK outflow and behavior. The aim of the present study was to fill in this gap by quantifying both the cortical CCK release and the behavior of rats subjected to a relevant stressful paradigm.
Social defeat, which results from exposure of a male rat to social agonistic encounters, is a situation frequently met in the natural habitat (Koolhaas et al., 1997). Convergent data have demonstrated that a social–aggressive encounter induces physiological evidence of stress, including elevations in plasma ACTH and corticosterone levels, increased heart rate and body temperature, and altered activity of neurochemically identified systems in brain (Miczek et al., 1991;Albonetti and Farabollini, 1994; Tornatzky and Miczek, 1994; Tidey and Miczek, 1996; Keeney and Hogg, 1999). Thus, this procedure can be considered as an appropriate model for the analysis of changes associated with social stress in rats.
The present paradigm was designed to study concomitantly the conditioned behavioral and biochemical consequences of the anticipation of social defeat. This was achieved by repeatedly subjecting experimental intruder rats to the threats by an aggressive conspecific resident, before being physically attacked and defeated. The effects of clinically efficient or putative anxiolytics on both behavioral parameters and cortical CCK release were examined under these experimental conditions.
MATERIALS AND METHODS
Animals
Male Sprague Dawley rats (Centre d'Élevage R. Janvier, Le Genest-St-Isle, France), weighing 250–300 gm, served as the experimental “intruder” animals. They were placed in individual cages (45 × 25 × 17 cm) for 10 d before the beginning of the experiments. Male Tryon Maze Dull S3 (TMD) rats (University of Limburg, Maastricht, The Netherlands), weighing 500–600 gm, served as “resident” rats in agonistic encounters. They were housed singly from weaning (at 3 weeks of age) in appropriate cages (45 × 45 × 17 cm). TMD rats are known as being spontaneously territorially aggressive animals and thereby dominant against intruders (Koolhaas et al., 1990). Ten TMD rats were used for the whole series of experiments performed in these studies. All animals were kept under controlled environmental conditions (22 ± 1°C, 60% relative humidity, 12 hr light/dark cycle, food and water ad libitum). Procedures involving animals and their care were all conducted in conformity with the institutional guidelines that are in compliance with national and international laws and policies (council directive #87–848 from the Ministère de l'Agriculture et de la Forêt, Service Vétérinaire de la Santé et de la Protection Animale).
Social defeat
Procedure. The behavioral procedure consisted of four daily conditioning sessions and one test session that involved the same pairs of residents and intruders. The 45 min conditioning sessions were divided into two consecutive periods. During period I (30 min), intruders were placed singly in a protective cage without cover (25 × 25 × 30 cm) inside the resident home cage. The resident home cage had no cover and was surrounded by a 100-cm-high wire-mesh enclosure (45 × 45 cm). The protective cage allowed unrestricted visual, auditory, and olfactory contacts with the resident but precluded close physical contact (Fig.1). During period II (15 min), the protective cage was removed. After the fourth conditioning session, i.e., the fifth day, intruders were implanted with a guide cannula (see below). Four days later, the experimental intruders implanted with the microdialysis probe (see below) were subjected to a single test session that consisted of a 30 min protected confrontation only.
Intruder rats were divided into two groups. During period II of each session, the resident was either present, allowing physical confrontation with the intruder (defeated intruders), or removed, while the intruder had access to the entire resident home cage (nondefeated intruders). Therefore, the nondefeated intruders were never physically attacked and defeated by the resident.
Behavioral quantification. The duration of immobility and 22 kHz ultrasonic vocalizations (USV) and the total number of rearings, wall-climbings (i.e., ascending the protective wire-mesh partition), and defensive–submissive postures (i.e., upright posture) were directly observed during period I of the four conditioning sessions and during the test session. USV were detected using a Batbox III (CEBA, Le Verdier, France), and behaviors were measured by two experienced observers who were blind to the treatment conditions.
Behavioral data were analyzed by two-way (subjects, sessions or subjects, drugs) ANOVAs followed, as appropriate, by pairwise comparisons using the Dunn's t test with the error variance term from ANOVAs.
Microdialysis
To estimate the in vitro recovery of CCK-like material (CCKLM), dialysis membrane was immersed at room temperature in an artificial CSF (aCSF) containing 0.25 or 0.50 ng/ml CCK-8S (Bachem, Bubendorf, Switzerland) and continuously perfused with aCSF at 3.0 μl/min. Two fractions (corresponding to 90 μl each, 30 min) were collected for each probe at each concentration of CCK-8S. The collected fractions, as well as 90 μl aliquots of the original solutions, were assayed for their CCKLM content by the radioimmunoassay (RIA) procedure described below. The relative recovery of a probe was calculated as the percentage of CCKLM quantified in the microdialysates over that present in the original solution. For the two CCK-8S concentrations tested, this ratio was constant: 8.2 ± 0.4% (mean ± SEM;n = 22). When the bath concentration of CCK-8S was changed from 0.25 to 0.50 ng/ml, equilibrium was reached within the 30 min collection period after this change.
Twenty-four hours after the fourth conditioning session, intruders were anesthetized with chloral hydrate (375 mg/kg, i.p.) and positioned in a stereotaxic frame (David Kopf Instruments, Tujunga, CA). The skull was exposed, and a 1 mm diameter hole was drilled for the descent of a stainless steel guide cannula (CMA/12; outer diameter, 0.7 mm; CMA Microdialysis, Stockholm, Sweden) with a “dummy probe.” Descent was made down to the following coordinates for the tip of the guide cannula just above the frontal cortex: anteroposterior, +2.7 mm from bregma; lateral, −1.7 mm from bregma; height, −0.8 mm from the skull (Paxinos and Watson, 1986). The cannula was then secured with dental cement to the skull, and the skin was sutured. Animals were allowed to recover from the surgery in individual cages for 4 d before the microdialysis experiment.
The day before the experiment, rats were placed in a Plexiglas microdialysis bowl (35 cm in diameter) with access to food and waterad libitum. The next morning, the dummy probe was removed, and a microdialysis probe (CMA/12; cutoff, 20,000 Da; outer diameter, 0.5 mm; 2 mm in length; CMA Microdialysis) was introduced into the guide cannula so as to protrude by 2 mm into the frontal cortex (Nevo et al., 1996). The probe was continuously perfused at a flow rate of 3.0 μl/min with aCSF (in mm: 146 NaCl, 3.0 KCl, 1.2 CaCl2, 1.0 MgCl2, 1.9 Na2HPO4, and 0.1 NaH2PO4, final pH 7.4) supplemented with bovine serum albumin (BSA) [0.025% w/v (Sigma, St. Louis, MO)] and peptidase inhibitors [0.03% w/v, bacitracin (Janssen, Geel, Belgium) and 0.1% w/v, polypep (Sigma)]. To allow dialysis to reach steady state around the membrane probe, perfusion was performed for 90 min (washout period) before collection of the first fraction (Nevo et al., 1996). In all experiments, 11 fractions of 90 μl (each corresponding to 30 min of perfusion) were collected at 0°C and then immediately frozen at −30°C until the determination of their CCKLM content using the RIA procedure described below.
During the microdialysis procedure, 118 min after collection of the first fraction, i.e., 2 min before collecting the fifth fraction, intruders (either defeated or nondefeated) were subjected to the behavioral test session. Each rat was gently moved to the protective cage placed inside the usual resident home cage for the 30 min test session and then back to the microdialysis bowl. This was done without having to detach the swivel arm. Thus, during the microdialysis procedure, intruders were threatened, but not defeated, by the resident.
At the end of the experiment, animals were deeply anesthetized with chloral hydrate and decapitated. Brains were removed and immediately frozen in isopentane cooled by dry ice. Placement of microdialysis probes was verified by histological examination. When the probe was incorrectly placed, the corresponding results were discarded (in only 2 of the 73 intruders used in the studies).
Drugs and treatments. The benzodiazepine receptor agonist diazepam (5 mg/kg; Hoffmann-La Roche, Basel, Switzerland), the selective CCK-B receptor antagonist CI-988 [2 mg/kg; Parke-Davis, Ann Arbor, MI (Hughes et al., 1990)], or the 5-HT1Areceptor agonist buspirone [0.5, 1.0, and 2.0 mg/kg; Bristol-Myers Squibb, Wallingford, CT) (Hamon, 1997)], were administered intraperitoneally to the intruder 30 min before its protected introduction into the resident home cage. The benzodiazepine receptor antagonist flumazenil [10 mg/kg, i.p.; Hoffmann-La Roche (Hunkeler et al., 1981)] was injected 5 min before the administration of diazepam. Buspirone was diluted in saline (0.9% w/v NaCl). Diazepam, flumazenil, and CI-988 were prepared as a suspension in acacia gum in distilled water. Intruders that received vehicle (3 ml/kg) were treated according to the same protocol.
CCKLM radioimmunoassay. The buffer used for preparing [125I]human gastrin solution (2000 Ci/mmol; CIS Bio International, Gif-sur-Yvette, France) and charcoal suspension was 50 mm barbital-HCl, pH 8.5, containing 1 gm/l sodium azide and 10 mmMgCl2. The anti-CCK-8 antiserum was obtained in a rabbit injected repeatedly with CCK-8 coupled to thyroglobulin by glutaraldehyde (Studler et al., 1981). For the measurement of CCKLM in microdialysates, 90 μl fractions were incubated with 100 μl of an anti-CCK antiserum solution [in barbital-HCl buffer containing 3.75 gm/l BSA; 1/1,500,000 final dilution (Benoliel et al., 1992)] and 50 μl of barbital-HCl buffer. After a 48 hr incubation at 4°C, 50 μl of the [125I]gastrin tracer solution (corresponding to 2000–2500 cpm) was added, and incubation proceeded for an additional 20–24 hr. The assay was stopped by adsorbing the free tracer onto active dextran T70-coated charcoal (4 and 40 gm/l, respectively, in the barbital-HCl buffer containing 10% horse serum; 1 ml of the suspension per tube). The tubes were immediately centrifuged at 6000 × g for 10 min at 4°C, and the radioactivity in the supernatants was estimated by gamma spectrometry. Standard curves were prepared from RIAs of standard solutions of 0.5–50 pg/tube of authentic CCK-8S in 50 μl of the barbital-HCl buffer supplemented with BSA. These aliquots were mixed with 90 μl of aCSF and 100 μl of the antiserum dilution, and RIAs then proceeded as described above. The detection limit of the assay was 0.75 pg of CCK-8S per tube, and half displacement of [125I]gastrin bound to antibodies was obtained with ∼10 pg of the peptide.
Under these RIA conditions, the cross-reactivity was 233% with nonsulfated CCK-8, 204% with gastrin, 31% with CCK-7S, 26% with nonsulfated CCK-7, 25% with CCK-5, 11% with CCK-33, and 1% with CCK-4, and was undetectable with rat α-calcitonin gene-related peptide (up to 2.5 μg/tube) compared with 100% for synthetic CCK-8S.
The CCKLM content of each fraction was expressed as CCK equivalents, i.e., the amount of authentic CCK-8S producing the same displacement of the radioiodinated tracer bound to anti-CCK antibodies as the endogenous material. These values were not corrected for probe recovery calculated from in vitro experiments with authentic CCK-8S. The effects of treatments were assessed by expressing the levels of CCKLM in each fraction collected after the treatment as a percentage of the mean levels of the peptide in the first three fractions collected immediately after the washout period. CCKLM in each fraction was compared with baseline level using paired Student's t test (two-tailed). Comparison between treated versus control groups for each fraction was made using one-way (drug) ANOVA followed, as appropriate, by the Dunn's t test with the error variance term from ANOVA.
RESULTS
Motor and social behavior of intruders during the four conditioning sessions of repeated defeat
During period I of the first conditioning session, i.e., before the first defeat episode, the intruders displayed high levels of activity as indicated by numerous rearings, wall-climbings, and short immobility duration (Fig.2A). USV and defensive–submissive postures were absent. During period II, when the protective cage was removed, intruders were immediately attacked and defeated by the residents. Defeat was indicated by full submissive posture, with the intruder laying motionless on its back with ventral surface exposed to the resident. The submissive postures seemed to reduce or suppress the resident aggressive behavior. Indeed, a total of three to four attacks (<10 sec each) only occurred during the 15 min period II, and intruders were only exceptionally wounded. These animals (only 3 of the 73 intruders used in these studies) were not included in the data reported herein.
During period I of the next three conditioning sessions (days 2–4), the defeated intruders were significantly less active (reduction of rearings and wall-climbings) than on the first session. In addition, they displayed defensive–submissive postures and emitted USV. These behaviors developed progressively over the successive sessions. The values of immobility, USV, and rearings measured during the fourth session were significantly different from those recorded during the second session.
In contrast, in nondefeated intruders, none of the behavioral parameters significantly varied during the four conditioning sessions (data not shown). In particular, on the fourth session, these animals displayed a lower level of immobility, a larger number of rearings and wall-climbings compared with defeated intruders, and no defensive–submissive postures or USV. Indeed, the values of all these parameters were not significantly different from those measured on the first conditioning session in the to-be defeated intruders.
Motor and social behavior of intruders during the microdialysis test session
Compared with behavioral parameters quantified during period I of the fourth conditioning session, there were no significant variations in those recorded during the microdialysis (fifth) test session (Fig.2, compare A, B). During the 30 min observation period, this behavior consisted primarily of immobility (session 4, 23.81 ± 0.99 min vs session 5, 25.73 ± 1.51 min; means ± SEM; n = 8; NS), USV (25.21 ± 0.74 vs 24.77 ± 1.01 min; NS), defensive–submissive postures (13.75 ± 1.53 vs 9.40 ± 1.57; NS), rearings (5.57 ± 1.16 vs 5.40 ± 1.21; NS), and wall-climbings (0.39 ± 0.24 vs 0.00 ± 0.00; NS). These five behavioral parameters recorded during the test session were significantly different from those quantified in nondefeated intruders (n = 6): immobility, 4.25 ± 1.35 min; numbers of rearings, 17.21 ± 2.82; wall-climbings, 16.63 ± 1.14; no USV and no submissive–defensive postures (Fig. 2B). The latter values were not significantly different from those measured in the same animals on the fourth conditioning session and on the first day in both the to-be defeated and nondefeated intruders.
Extracellular cortical levels of CCKLM in intruders
The spontaneous CCKLM outflow (i.e., fractions 1–3 measured 120–30 min before exposure to resident) in defeated intruders was not significantly different from that measured in nondefeated intruders (1.35 ± 0.13 pg of CCK equivalents per fraction; mean ± SEM; n = 8; vs 1.39 ± 0.08;n = 6, respectively) (Fig.3).
When defeated intruders were placed into the protective cage inside the home cage of the resident, a significant elevation of CCKLM extracellular levels was observed in the corresponding (fifth) microdialysate fraction (+99 ± 12%; p < 0.001;n = 8). Subsequently, CCKLM levels returned to basal values and remained stable until the end of the experiment. In nondefeated intruders, introduction into the home cage of the resident did not significantly modify cortical CCKLM outflow.
Effects of diazepam, buspirone, or CI-988 on behavior and extracellular CCKLM levels
Behavior
Injection of saline or suspension of acacia gum in distilled water, 30 min before the 30 min protected confrontation, did not significantly affect the behavior of both defeated and nondefeated intruders compared with noninjected intruders (Table1, Fig. 2B).
Table 1.
Acacia gum (n = 7) | Diazepam (5 mg/kg) (n = 8) | Flumazenil (10 mg/kg) plus diazepam (5 mg/kg) (n = 6) | CI-988 (2 mg/kg) (n = 10) | ||
---|---|---|---|---|---|
Immobility (minutes) | ND | 4.23 ± 0.90 | 21.83 ± 1.75‡ | 4.42 ± 0.301-221 | 5.85 ± 1.51 |
D | 25.14 ± 1.131-164 | 25.40 ± 0.57 | 24.09 ± 1.091-164 | 6.89 ± 1.861-160 | |
USV (minutes) | ND | 0 | 0.86 ± 0.53 | 0 | 0 |
D | 25.35 ± 1.081-164 | 3.69 ± 2.601-160 | 22.50 ± 1.241-164,1-223 | 7.47 ± 1.601-160,† | |
Defensive–submissive postures (numbers per 30 min) | ND | 0 | 0 | 0 | 0 |
D | 10.00 ± 1.53† | 0.67 ± 0.331-160 | 8.50 ± 1.60†,1-222 | 4.75 ± 2.21* | |
Rearings (numbers per 30 min) | ND | 18.28 ± 2.13 | 8.60 ± 1.21‡ | 19.33 ± 2.401-221 | 19.61 ± 2.30 |
D | 4.05 ± 0.441-164 | 8.33 ± 0.58* | 4.25 ± 0.761-164,1-222 | 23.81 ± 4.401-160 | |
Wall-climbings (numbers per 30 min) | ND | 17.62 ± 1.86 | 3.22 ± 1.33‡ | 17.67 ± 1.201-221 | 17.54 ± 1.82 |
D | 01-164 | 3.17 ± 0.60* | 0.25 ± 0.251-164,1-222 | 15.60 ± 1.621-160 |
Behavior of nondefeated or defeated intruders was recorded in the course of the microdialysis experiment during the 30 min protected exposure to a resident, starting 30 min after diazepam (5 mg/kg, i.p.), CI-988 (2 mg/kg, i.p.), or acacia gum injection. Flumazenil (10 mg/kg, i.p.) was injected 5 min before diazepam. The five behavioral parameters were quantified as indicated in the legend to Figure 2. Data are the means ± SEM of data obtained in n (6–10) rats.
p < 0.01 versus nondefeated intruders given acacia gum.
p < 0.05,
F1-164: p < 0.01 versus nondefeated intruders given the same treatment.
F1-222: p < 0.05,
F1-223: p < 0.01 defeated intruders treated with flumazenil plus diazepam versus defeated intruders given diazepam.
p < 0.05,
F1-160: p < 0.01 versus defeated intruders given acacia gum.
F1-221: p < 0.01 nondefeated intruders treated with flumazenil plus diazepam versus nondefeated intruders given diazepam.
In nondefeated intruders, diazepam (5 mg/kg, i.p.) significantly decreased the number of rearings and wall-climbings and lengthened immobility time. These effects were completely prevented by flumazenil (10 mg/kg, i.p., 5 min before diazepam), which, on its own, significantly affected none of the five behavioral parameters measured (data not shown). Similarly, CI-988 (2 mg/kg, i.p.) (Table 1) and buspirone at three different doses (0.5, 1.0 and 2.0 mg/kg, i.p., 30 min before the protected confrontation) (data not shown) did not significantly change these parameters.
In defeated intruders, diazepam significantly reduced the duration of USV and the number of submissive–defensive postures, whereas the numbers of wall-climbings and rearings were increased when compared with acacia gum-injected intruders. These effects were completely prevented by flumazenil (Table 1), which, on its own, affected none of the five behavioral parameters quantified in the defeated intruders (data not shown). The CCK-B receptor antagonist CI-988 significantly reduced the time spent immobile and vocalizing, as well as the number of defensive–submissive postures, and enhanced rearings and wall-climbings (Table 1). Indeed, for defeated intruders treated with diazepam or CI-988, the values of all the measured parameters were not significantly different from those recorded in their nondefeated counterparts (except the duration of vocalization in CI-988-treated animals) (Table 1). In contrast, buspirone (0.5, 1.0, and 2.0 mg/kg, i.p.) did not significantly alter any of the five behavioral parameters in defeated intruders (data not shown).
Extracellular cortical levels of CCKLM in intruders
In both nondefeated (data not shown) and defeated intruders, neither saline, acacia gum, diazepam, buspirone, nor CI-988 affected the extracellular cortical levels of CCKLM before the protected confrontation to the resident (fraction 4) (Fig.4).
In defeated intruders, acacia gum or saline did not modify stress-induced CCKLM overflow (compare Figs. 3,4A,B). In contrast, diazepam completely abolished the increase in CCKLM contents in the fraction (fifth) collected during the 30 min protected confrontation to the resident (Fig. 4A). As illustrated in Figure4A, flumazenil pretreatment (inactive on its own) (data not shown) prevented the effect of diazepam, and stress-induced CCKLM overflow in defeated intruders treated with the combination of these two drugs did not significantly differ from that measured in defeated intruders injected with the vehicle only. Similarly, CCKLM overflow was unaltered in defeated intruders treated with either CI-988 (Fig. 4A) or buspirone (at 0.5, 1.0, and 2.0 mg/kg) (Fig. 4B) compared with vehicle-treated defeated intruders.
DISCUSSION
The present study shows that the anticipation of social defeat increased cortical CCKergic neurotransmission in rats. This effect seems in relation to stress and/or anxiety because the protocol used herein produced behaviors that could be related to this state. Moreover, the increase of cortical extracellular levels, as well as the anxiety-related behaviors, could be prevented by the potent anxiolytic drug diazepam, whereas the CCK-B receptor antagonist CI-988 reduced the behaviors only. That the 5-HT1A receptor agonist buspirone had no effect on behavioral responses and CCKLM release associated with anticipation of social defeat suggests that this drug did not possess anxiolytic properties in this paradigm. All of these data show the existence of a close parallelism between the activation of cortical CCKergic neurotransmission and stress and/or anxiety-driven behavior in defeated rats.
The experimental procedure used in the present study was essentially based on that described by Miczek and his coworkers (Tornatzky and Miczek, 1994; Tidey and Miczek, 1996), who established that the paradigm consisting of confrontations between an intruder and a resident rat on 4 consecutive days represents a social stress that offers the advantages of ecological and ethological validity. The major difference that we introduced in this paradigm is the timeline during the four conditioning sessions. In the procedure described by Miczek and his coworkers, intruders were placed in a protective cage after the defeat, whereas, in the present study, the 30 min protected session always preceded the defeat. Therefore, this procedure allowed us to investigate the anticipation of the defeat (psychosocial stress).
During the first exposure of the intruder, in a protective cage, to the resident, the intruder clearly displayed exploratory behavior as evidenced by numerous rearings and wall-climbings. In contrast, from the second session onward, rats defeated during period II of the preceding session exhibited clear-cut changes in behavior; rearings progressively declined and wall-climbings almost completely disappeared, whereas the immobility time progressively lengthened. In addition, the defeated intruders adopted defensive–submissive postures and emitted USV for a long duration. In rats subjected to the same protected confrontation, but not to the physical defeat by the resident (nondefeated intruders), none of the locomotor or social behaviors significantly changed throughout the five successive social encounters. In defeated intruders, the reduction of exploratory behavior cannot be accounted for by habituation because it was not observed in nondefeated intruders. During agonistic encounters with the resident animals (period II), the defeated intruders emitted USV in conjunction with defensive and submissive behavior (data not shown). In contrast, no USV were recorded before the first defeat. The appearance of USV in period I as soon as on the second conditioning session emphasizes the importance of the socially relevant context to generate USV. USV, particularly at low frequency (20–30 kHz), are emitted in response to various anxiogenic events, including social defeat (Sales, 1972; de Vry et al., 1993; Vivian and Miczek, 1993; Tornatzky and Miczek, 1994). In line with this interpretation, Blanchard et al. (1991) reported that the presentation of a cat to a rat led the latter to produce USV (22 kHz) that occurred over the same period as freezing. On the other hand, previous studies (Vivian and Miczek, 1993; Tornatzky and Miczek, 1994) established that defensive–submissive postures can be related to state of fear and/or anxiety.
The behavior exhibited by the defeated intruders during the anticipation of defeat on the fifth experimental session did not significantly differ from that noted on the fourth confrontation session performed 4 d before. Indeed, on the microdialysis day, the protected confrontation of the intruders to the resident resulted in submissive–defensive postures, USV, and almost complete suppression of motor or exploratory behavior. These behaviors were associated with a marked increase in extracellular CCKLM levels in the frontal cortex. This effect lasted for the 30 min confrontation only, because CCKLM outflow returned to the baseline value and remained stable thereafter, up to the end of the experiment. In nondefeated intruders, neither behavior nor extracellular CCKLM levels were affected by the protected confrontation to the residents. This strongly suggests that the behavioral responses and the increase in cortical CCKLM outflow in defeated intruders could be attributed to the anticipatory “fear” of encountering an animal that had previously attacked and defeated them.
We have shown previously that exposure to other uncontrollable aversive stimuli, such as restraint stress, yohimbine administration, or ether inhalation, induced an increase in cortical CCKLM release in rats (Nevo et al., 1996; Becker et al., 1999). In the present study, the fact that the enhanced CCKLM outflow was observed during the anticipatory phase of a defeat episode and was abolished by the established anxiolytic diazepam further strengthens the anxiety-like interpretation of the situation. Furthermore, diazepam treatment also produced a marked decrease in the vocalization time and the number of defensive–submissive postures and an increased number of rearings and wall-climbings. These effects were actually attributable to the stimulation of benzodiazepine receptors because they were prevented by the benzodiazepine receptor antagonist flumazenil at a dose (10 mg/kg, i.p.) that blocks diazepam-induced behaviors (Ida et al., 1985; Rowlett and Woolverton, 1996; Matto et al., 1997). In line with the present data, diazepam, reported to act on the motivational or threat intensity dimension, was already shown to reduce vocalization in the Fear/Defense Test Battery (Blanchard et al., 1990) and in a social stress paradigm in rats (Tornatzky and Miczek, 1991). The fact that the increased time spent immobile in defeated intruders was not reversed by diazepam might be accounted for by the sedative effect of this benzodiazepine (Haefely et al., 1981). Accordingly, immobility was clearly lengthened in nondefeated intruders given diazepam, and this effect could be prevented by flumazenil.
In contrast to diazepam, the 5-HT1A receptor agonist buspirone, at doses (0.5–2.0 mg/kg, i.p.) known to possess anxiolytic properties in some paradigms (Griebel, 1995), prevented neither the behavioral manifestations nor the enhancement of cortical extracellular CCKLM levels that accompanied the anticipation of a defeat episode. The lack of effect of buspirone on both behavioral and biochemical parameters indicated that the increased release of CCK did not result from some excitatory influence of 5-HT acting at 5-HT1A receptors. We showed previously that buspirone (1 mg/kg, i.p.) counteracted the increase in cortical extracellular CCKLM levels induced by restraint stress or administration of the anxiogenic compound yohimbine (Becker et al., 1999). This would indicate that the anxiolytic-like effects of 5-HT1A receptor agonists depend on the anxiogenic–stress procedure used and sustains the opinion that conflict paradigms are less sensitive to the action of these compounds than unconditioned models (Griebel, 1995).
To investigate whether CCKLM overflow could be responsible, at least partly, for the behavioral responses in defeated intruders during the 30 min protected exposure to the resident, we attempted to prevent these responses by blocking CCK receptors. Although CI-988 has rather poor bioavailability and blood–brain barrier permeability, we chose this antagonist because it possesses a nanomolar affinity for CCK-B receptors and exhibits a good selectivity for CCK-B over CCK-A receptors (Noble et al., 1999). Indeed, numerous convergent studies previously demonstrated that the anxiogenic effects of CCK are mediated through the stimulation of CCK-B receptors (see references in the introductory remarks). The administration of CI-988 affected neither the spontaneous outflow of CCKLM nor the stress-induced CCKLM overflow in the frontal cortex of intruders, thereby suggesting that CCK release from CCKergic terminals may not be controlled by CCK autoreceptors. However, CI-988 markedly reduced all of the anxiety-like behaviors in defeated intruders. Thus, among the five parameters measured, only USV duration did not return to control values in CI-988-pretreated animals. Indeed, although still longer than in nondefeated intruders, the duration of USV was significantly reduced in CI-988-pretreated compared with nontreated defeated intruders. At the dose used in our studies, 2 mg/kg intraperitoneally, CI-988 exerts clear-cut anxiolytic-like effects in various paradigms (Singh et al., 1991; Izumi et al., 1996;Adamec et al., 1997). Accordingly, the present results further support the idea that the activation of cortical CCKergic neurotransmission closely paralleled stress- and/or anxiety-driven behaviors in rats. It can be reasonably assumed that CCK itself contributed to these behaviors because they could be significantly reduced by the blockade of the actions of the peptide by CI-988.
In conclusion, the present study showed that anticipation of social defeat produces an anxiety-like state that is associated with an increase in cortical CCKergic neurotransmission. Furthermore, the latter event appeared to be probably involved in the genesis of anxiety-like behaviors. The experimental paradigm used herein should be suitable for both investigating the implication of other neuronal systems in anticipatory fear and assessing the potential anxiolytic properties of drugs.
Footnotes
This research was supported by grants from Institut National de la Santé et de la Recherche Médicale and Bristol-Myers Squibb Foundation (Unrestricted Biomedical Research Grant). C.B. was recipient of a fellowship from the Ministère de l'Education Nationale, de l'Enseignement Supérieur et de la Recherche during performance of this work. We are grateful to Dr. D. Le Bars and Dr. C. Spielewoy for helpful discussions, B. Zeau for excellent technical assistance, and pharmaceutical companies for generous gifts of buspirone (Bristol-Myers Squibb, Wallingford, CT) and CI-988 (Parke-Davis, Ann Arbor, MI).
Correspondence should be addressed to Jean-Jacques Benoliel, Institut National de la Santé et de la Recherche Médicale U. 288, NeuroPsychoPharmacologie Moléculaire, Cellulaire et Fonctionnelle, Faculté de Médecine Pitié-Salpêtrière, 75634 Paris Cedex 13, France. E-mail: benoliel@ccr.jussieu.fr.
REFERENCES
- 1.Adamec RE, Shallow T, Budgel J. Blockade of CCKB but not CCKA receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder. Behav Neurosci. 1997;111:435–449. doi: 10.1037//0735-7044.111.2.435. [DOI] [PubMed] [Google Scholar]
- 2.Albonetti ME, Farabollini F. Social stress by repeated defeat: effects on social behaviour and emotionality. Behav Brain Res. 1994;62:187–193. doi: 10.1016/0166-4328(94)90027-2. [DOI] [PubMed] [Google Scholar]
- 3.Becker C, Hamon M, Benoliel J-J. Prevention by 5-HT1A receptor agonists of restraint stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of the freely moving rat. Neuropharmacology. 1999;38:525–532. doi: 10.1016/s0028-3908(98)00209-3. [DOI] [PubMed] [Google Scholar]
- 4.Beinfeld MC, Meyer DK, Eskay RL, Jensen RT, Brownstein MJ. The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay. Brain Res. 1981;212:51–57. doi: 10.1016/0006-8993(81)90031-7. [DOI] [PubMed] [Google Scholar]
- 5.Benoliel J-J, Bourgoin S, Mauborgne A, Pohl M, Legrand JC, Hamon M, Cesselin F. GABA, acting at both GABAA and GABAB receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro. Brain Res. 1992;590:255–262. doi: 10.1016/0006-8993(92)91103-l. [DOI] [PubMed] [Google Scholar]
- 6.Blanchard DC, Blanchard RJ, Rodgers RJ. Pharmacological and neural control of anti-predator defense in the rat. Aggress Behav. 1990;16:165–175. [Google Scholar]
- 7.Blanchard RJ, Blanchard DC, Agullana R, Weiss SM. Twenty-two kHz alarm cries to presentation of a predator, by laboratory rats living in visible burrow systems. Physiol Behav. 1991;50:967–972. doi: 10.1016/0031-9384(91)90423-l. [DOI] [PubMed] [Google Scholar]
- 8.Bradwejn J, Koszycki D, Meterissian G. Cholecystokinin tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry. 1990;35:83–85. doi: 10.1177/070674379003500115. [DOI] [PubMed] [Google Scholar]
- 9.Bradwejn J, Koszycki D, Couëtoux du Tertre A, van Megen H, den Boer J, Westenberg H, Annable L. The panicogenic effects of chole-cystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry. 1994;51:486–493. doi: 10.1001/archpsyc.1994.03950060050005. [DOI] [PubMed] [Google Scholar]
- 10.Brodin K, Rosen A, Iwarsson K, Ogren SO, Brodin E. Increased levels of substance-P and cholecystokinin in rat cerebral cortex following repeated electroconvulsive shock and subchronic treatment with serotonin uptake inhibitor. Acta Physiol Scand. 1989;136:613–614. doi: 10.1111/j.1748-1716.1989.tb08710.x. [DOI] [PubMed] [Google Scholar]
- 11.Daugé V, Léna I. CCK in anxiety and cognitive processes. Neurosci Biobehav Rev. 1998;22:815–825. doi: 10.1016/s0149-7634(98)00011-6. [DOI] [PubMed] [Google Scholar]
- 12.de Montigny C. Cholecystokinin-tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psychiatry. 1989;46:511–517. doi: 10.1001/archpsyc.1989.01810060031006. [DOI] [PubMed] [Google Scholar]
- 13.de Vry J, Benz U, Schreiber R, Traber J. Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs. Eur J Pharmacol. 1993;249:331–339. doi: 10.1016/0014-2999(93)90530-u. [DOI] [PubMed] [Google Scholar]
- 14.Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacol Ther. 1995;65:319–395. doi: 10.1016/0163-7258(95)98597-j. [DOI] [PubMed] [Google Scholar]
- 15.Haefely W, Pieri L, Polc P, Schaffner R. General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Hoffmeister F, Stille G, editors. Handbook of experimental pharmacology. Springer; Berlin: 1981. pp. 13–262. [Google Scholar]
- 16.Hamon M. The main features of central 5-HT1A receptors. In: Baumgarten HG, Göthert M, editors. Serotoninergic neurons and 5-HT receptors in the CNS. In: Handbook of Experimental Pharmacology. Springer; Berlin: 1997. pp. 239–268. [Google Scholar]
- 17.Harro J, Kiivet R-A, Lang A, Vasar E. Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav Brain Res. 1990;39:63–71. doi: 10.1016/0166-4328(90)90121-t. [DOI] [PubMed] [Google Scholar]
- 18.Harro J, Jossan SS, Oreland L. Changes in cholecystokinin receptor binding in rat brain after selective damage of the locus coeruleus projections by DSP-4 treatment. Naunyn Schmiedebergs Arch Pharmacol. 1992;364:425–431. doi: 10.1007/BF00171085. [DOI] [PubMed] [Google Scholar]
- 19.Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN. Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity. Proc Natl Acad Sci USA. 1990;87:6728–6732. doi: 10.1073/pnas.87.17.6728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hunkeler W, Mohler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W. Selective antagonists of benzodiazepines. Nature. 1981;290:514–516. doi: 10.1038/290514a0. [DOI] [PubMed] [Google Scholar]
- 21.Iadarola MJ, Naranjo JR, Duchemin AM, Quach TT. Expression of cholecystokinin and enkephalin mRNA in discrete brain regions. Peptides. 1989;10:687–692. doi: 10.1016/0196-9781(89)90160-5. [DOI] [PubMed] [Google Scholar]
- 22.Ida Y, Tanaka M, Tsuda A, Tsujimaru S, Nagasaki N. Attenuating effect of diazepam on stress-induced increases in noradrenaline turnover in specific brain regions of rats: antagonism by Ro 15–1788. Life Sci. 1985;37:2491–2498. doi: 10.1016/0024-3205(85)90606-x. [DOI] [PubMed] [Google Scholar]
- 23.Izumi T, Inoue T, Tsuchiya K, Hashimoto S, Ohmori T, Koyama T. Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats. Eur J Pharmacol. 1996;300:25–31. doi: 10.1016/0014-2999(95)00859-4. [DOI] [PubMed] [Google Scholar]
- 24.Keeney AJ, Hogg S. Behavioural consequences of repeated social defeat in the mouse: preliminary evaluation of a potential animal model of depression. Behav Pharmacol. 1999;10:753–764. doi: 10.1097/00008877-199912000-00007. [DOI] [PubMed] [Google Scholar]
- 25.Koolhaas JM, Hermann PM, Kemperman C, Bohus B, van den Hoofdakker RH, Beersma DGM. Single social defeat in male rats induces a gradual but long lasting behavioural change: a model of depression? Neurosci Res Commun. 1990;7:35–41. [Google Scholar]
- 26.Koolhaas JM, Meerlo P, De Boer SF, Strubbe JH, Bohus B. The temporal dynamics of the stress response. Neurosci Biobehav Rev. 1997;6:775–782. doi: 10.1016/s0149-7634(96)00057-7. [DOI] [PubMed] [Google Scholar]
- 27.Marley PD, Rehfeld JF, Emson PC. Distribution and chromatographic characterisation of gastrin and cholecystokinin in the rat central nervous system. J Neurochem. 1984;42:1523–1535. doi: 10.1111/j.1471-4159.1984.tb12738.x. [DOI] [PubMed] [Google Scholar]
- 28.Matto V, Harro J, Allikmets L. The effects of cholecystokinin A and B receptor antagonists on exploratory behaviour in the elevated zero-maze in rat. Neuropharmacology. 1997;36:389–396. doi: 10.1016/s0028-3908(97)00011-7. [DOI] [PubMed] [Google Scholar]
- 29.Miczek KA, Thompson ML, Tornatzky W. Subordinate animals: behavioral and physiological adaptations and opioid tolerance. In: Brown MR, Koob GF, Rivier C, editors. Neurobiology of stress. Dekker; New York: 1991. pp. 323–357. [Google Scholar]
- 30.Nevo I, Becker C, Hamon M, Benoliel J-J. Stress- and yohimbine-induced release of cholecystokinin in the frontal cortex of freely moving rat: prevention by diazepam but not ondansetron. J Neurochem. 1996;66:2041–2049. doi: 10.1046/j.1471-4159.1996.66052041.x. [DOI] [PubMed] [Google Scholar]
- 31.Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M, Roques BP. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev. 1999;51:745–781. [PubMed] [Google Scholar]
- 32.Paxinos P, Watson C. The rat brain in stereotaxic coordinates, Ed 2. Academic; Sydney: 1986. [DOI] [PubMed] [Google Scholar]
- 33.Rowlett JK, Woolverton WL. Assessment of benzodiazepine receptor heterogeneity in vivo: apparent pA2 and pKB analyses from behavioral studies. Psychopharmacology. 1996;128:1–16. doi: 10.1007/s002130050103. [DOI] [PubMed] [Google Scholar]
- 34.Sales GD. Ultrasound and aggressive behaviour in rats and other small mammals. Anim Behav. 1972;20:88–100. doi: 10.1016/s0003-3472(72)80177-5. [DOI] [PubMed] [Google Scholar]
- 35.Shlick J, Vasar E, Bradwejn J. Cholecystokinin and psychiatric disorders. Role in aetiology and potential of receptor antagonists in therapy. Cent Nerv Syst Drugs. 1997;8:134–152. doi: 10.2165/00023210-199708020-00005. [DOI] [PubMed] [Google Scholar]
- 36.Siegel RA, Düker EM, Fuchs E, Pahnke U, Wuttke W. Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance-P neuronal systems to stress, in the male rat. Neurochem Int. 1984;6:783–789. doi: 10.1016/0197-0186(84)90011-1. [DOI] [PubMed] [Google Scholar]
- 37.Singh L, Field MJ, Hughes J, Menzies R, Oles RJ, Vass CA, Woodruff GN. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist. Br J Pharmacol. 1991;104:239–245. doi: 10.1111/j.1476-5381.1991.tb12413.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Studler JM, Simon H, Cesselin F, Legrand JC, Glowinski J, Tassin JP. Biochemical investigation on the localization of the cholecystokinin octapeptide in dopaminergic neurons originating from the ventral tegmental area of the rat. Neuropeptides. 1981;2:131–139. [Google Scholar]
- 39.Tidey JW, Miczek KA. Social defeat stress selectively alters mesocorticolimbic dopamine release: an in vivo microdialysis study. Brain Res. 1996;721:140–149. doi: 10.1016/0006-8993(96)00159-x. [DOI] [PubMed] [Google Scholar]
- 40.Tornatzky W, Miczek KA. Behavior and physiology of socially stressed rats: anti- and pro-stress effects of anxiolytics. Soc Neurosci Abstr. 1991;17:147. [Google Scholar]
- 41.Tornatzky W, Miczek KA. Behavioral and autonomic responses to intermittent social stress: differential effects of clonidine and metoprolol. Psychopharmacology. 1994;116:346–356. doi: 10.1007/BF02245339. [DOI] [PubMed] [Google Scholar]
- 42.van Megen HJGM, Westenberg HGM, den Boer JA, Kahn RS. Cholecystokinin in anxiety. Eur Neuropsychopharmacol. 1996;6:263–280. doi: 10.1016/s0924-977x(96)00038-7. [DOI] [PubMed] [Google Scholar]
- 43.Vasar E, Peuranen E, Harro J, Lang A, Oreland L, Männistö PT. Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein. Naunyn Schmiedebergs Arch Pharmacol. 1993;348:96–101. doi: 10.1007/BF00168543. [DOI] [PubMed] [Google Scholar]
- 44.Vivian JA, Miczek KA. Diazepam and gepirone selectively attenuate either 20–32 kHz or 32–64 kHz ultrasonic vocalizations during aggressive encounters. Psychopharmacology. 1993;113:66–73. doi: 10.1007/BF02247364. [DOI] [PubMed] [Google Scholar]